Why - as it stands - takeover of Mead Johnson is unlikely
A new year, re-heated M&A speculation. Takeover talk is again centred on US-based infant formula group Mead Johnson, often seen as a target since it was spun off by pharma group Bristol-Myers Squibb in 2009. In the past, the chatter has focused on whether Danone would buy the Enfamil maker. Now, Nestle is in the spotlight. However, as Dean Best reports, such a deal looks unlikely - and, at present, the prospect of other suitors coming in appears just as slim.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 17 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Analysis: Post discusses rationale for Weetabix
- Interview: Sir Kensington's on sale to Unilever
- US food next wave on display at Winter Fancy Food
- Column: Why snacking is the new meal
- Who will buy Danone's Stonyfield business?
- Unilever buys US condiments maker Sir Kensington's
- Ice cream helps Unilever sales, food flat
- Suntory to offload Australia, New Zealand foods
- Post: Weetabix "opens up M&A opportunities"
- Nestle organic growth slows but beats expectations